• Waniwani

  Participated · Seed · Jun 2026

  Waniwani offers an open-source software development kit that lets insurance, mortgage, home services and other quote-based vendors build sales agents for AI platforms like ChatGPT, Claude and Google Gemini, as well as channels such as WhatsApp. It monetizes via a paid infrastructure layer that provides compliance and regulatory monitoring, funnel simulation and analytics, pricing optimization and anti-scraping protection. The company reports clients across Europe, Latin America, the Middle East, South Korea, Australia and the US, and says it is on track to generate several million dollars in revenue in its first year. Waniwani has a strategic partnership with Deloitte UK and has powered ChatGPT applications announced by Aviva and MONY Group. Founders include CEO Robin Diligent, former BCG generative AI lead, Raphaël Vullierme, co-founder of Luko, CTO Maxime Antoine, and Luiza Gusmao, formerly VP at Cover Genius. The company plans to expand its SDK and paid modules and pursue further international growth.

• Corgi

  Participated · Series B · May 2026

  Corgi is an AI-native, full-stack insurance carrier founded by Emily Yuan and Nico Laqua and headquartered in San Francisco. As a licensed carrier, it designs and manages insurance end-to-end and uses AI to power underwriting, policy management, and claims operations. The company launched its platform after receiving regulatory approval in July 2025 and initially focused on property-management insurance for startups. Corgi plans to expand its product suite into new verticals including trucking, payroll, and small-business insurance while broadening coverage and distribution. Financially, Corgi has raised over $268 million to date, including a $160 million Series B at a $1.3 billion valuation. The company is investing the new capital in AI systems, faster quoting, adaptive risk models, and operational scaling to support its growth plans.

• Generation Lab

  Participated · Seed · Oct 2025

  Generation Lab is a San-Francisco–based longevity science company whose flagship product, SystemAge™, quantifies biological age by analyzing primary blood data and evaluating the health of 19 physiological systems. The platform relies on hundreds of millions of human-aging data points and proprietary algorithms that achieve 99.9% diagnostic accuracy, offering clinicians and consumers actionable insights to slow or reverse organ-specific aging. Launched less than ten months ago, the company has already partnered with more than 275 clinics worldwide and amassed over 300 million data points, reflecting rapid commercial traction. Early clinical studies have shown measurable reversals of brain, reproductive, heart and immune system ages after targeted interventions, underscoring its clinical relevance. Generation Lab’s customer base includes academic medical centers, professional athletes, celebrities, and leading longevity physicians. Backed by prominent scientific advisors such as Harvard’s David Sinclair and George Church, the company aims to make proactive longevity diagnostics a global standard of care. With $15 million in total funding, Generation Lab plans to accelerate adoption of SystemAge™ and continue expanding its dataset and intervention roadmap.

No current team members are available.